French National Institute of Health and Medical Research, INSERM U988 & U710, Paris & Montpellier, France.
Arch Public Health. 2013 Feb 4;71(1):2. doi: 10.1186/0778-7367-71-2.
Life expectancy has been increasing during the last century within the European Union (EU). To measure progress in population health it is no longer sufficient to focus on the duration of life but quality of life should be considered. Healthy Life Years (HLY) allow estimating the quality of the remaining years that a person is expected to live, in terms of being free of long-standing activity limitation. The Joint Action on Healthy Life Years (JA: EHLEIS) is a joint action of European Member States (MS) and the European Union aiming at analysing trends, patterns and differences in HLY, as well as in other Summary Measures of Population Health (SMPH) indicators, across the European member states.
The JA: EHLEIS consolidates existing information on life and health expectancy by maximising the European comparability; by analysing trends in HLY within the EU; by analysing the evolution of the differences in HLY between Member States; and by identifying both macro-level as micro-level determinants of the inequalities in HLY. The JA: EHLEIS works in collaboration with the USA, Japan and OECD on the development of new SMPHs to be used globally. To strengthen the utility of the HLY for policy-making, annual meetings with policy-makers are planned.
The information system allows the estimation of a set of health indicators (morbidity and disability prevalence, life and health expectancies) for Europe, Member States and shortly their regional levels. An annual country report on HLY in the national languages is available. The JA: EHLEIS is developing statistical attribution and decomposition tools which will be helpful to determine the impact of specific diseases, life styles or other determinants on differences in HLY. Through a set of international workshops the JA: EHLEIS aims to develop a blueprint for an international harmonized Summary Measure of Population Health.
The JA: EHLEIS objectives are to monitor progress towards the headline target of the Europe 2020 strategy of increasing HLY by 2 years by 2020 and to support policy development by identifying the main determinants of active and healthy ageing in Europe.
在上个世纪,欧盟(EU)的预期寿命一直在增加。为了衡量人口健康的进展,仅仅关注生命的持续时间已经不够了,还应该考虑生活质量。健康期望寿命(HLY)可以估计一个人在没有长期活动受限的情况下预期剩余寿命的质量。健康期望寿命联合行动(JA:EHLEIS)是欧盟成员国(MS)和欧盟的一项联合行动,旨在分析整个欧洲成员国的 HLY 以及其他人口健康综合衡量指标(SMPH)的趋势、模式和差异。
JA:EHLEIS 通过最大化欧洲的可比性来整合关于预期寿命和健康预期的现有信息;分析欧盟内 HLY 的趋势;分析成员国之间 HLY 差异的演变;并确定 HLY 不平等的宏观和微观决定因素。JA:EHLEIS 与美国、日本和经合组织合作,开发新的全球使用的 SMPH。为了增强 HLY 在决策中的实用性,计划与决策者举行年度会议。
信息系统允许估计一套健康指标(发病率和残疾流行率、预期寿命和健康预期寿命),涵盖欧洲、成员国及其区域层面。每年以本国语言提供关于 HLY 的国家报告。JA:EHLEIS 正在开发统计归因和分解工具,这将有助于确定特定疾病、生活方式或其他决定因素对 HLY 差异的影响。通过一系列国际研讨会,JA:EHLEIS 旨在制定国际统一人口健康综合衡量指标蓝图。
JA:EHLEIS 的目标是监测 2020 年欧洲战略提高 HLY 的主要目标的进展,到 2020 年增加 2 年,并通过确定欧洲积极健康老龄化的主要决定因素来支持政策制定。